Genotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies
Nephrology Dialysis Transplantation · 2025
DOI: 10.1093/ndt/gfaf086 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Susan M McAnallen und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: TRPC6 Cation Channel, Genetic Association Studies, Podocytes, Kidney Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Physicians of Ireland, MRC, Northern Counties Kidney Research Fund.
Abstract (Originalsprache)
Background and hypothesis Podocytopathy associated with likely pathogenic/pathogenic variants of Transient receptor potential cation channel subfamily C member 6 (TRPC6) (TRPC6-AP) has been recognized for about 20 years. As a result of its rarity however, the spectrum of clinical phenotypes and genotype–phenotype correlation of TRPC6-AP remains poorly understood. Here, we characterized clinical, histological and genetic correlates of familial and sporadic patients with TRPC6-AP.
Methods
In this multicentre observational study, an online questionnaire followed by a systematic literature review was performed to create a cohort with comprehensive data on genetic and clinical outcomes [age of onset, clinical presentation, treatment response, kidney biopsy findings and progression to kidney failure (KF)]. Logistic regression, Cox proportional hazards model and Kaplan–Meier analyses investigated the associations between genetic variants and disease progression.
Results
Among 87 families (96 familial and 45 sporadic cases), 31 distinct missense TRPC6 variants (including 2 novel) were identified, with c.2683C>T p.(Arg895Cys) and c.523C>T p.(Arg175Trp) the commonest variants. Proteinuric kidney disease/nephrotic syndrome was the most common clinical presentation (83.7%), while focal segmental glomerulosclerosis was the most common histological finding (89.4%). By 33 (interquartile range 17–40) years, 48.9% (69/141) of patients had progressed to KF. Sporadic TRPC6-AP demonstrated an earlier progression to KF than familial cases (P = .001) and were more likely to present with nephrotic syndrome [odds ratio 4.34 (1.85–10.15); P = .001]. Gain-of-function TRPC6 variants were more frequent in familial than sporadic TRPC6-AP (70.8% vs 44.4%; P = .004). Compared with patients with other TRPC6 variants, patients with TRPC6 p.R175W and p.R895C variants progressed to KF earlier [median kidney survival of 21 years, hazard ratio 2.985 (95% confidence interval 1.40–5.79); and 38 years, hazard ratio 1.65 (95% confidence interval 1.01–2.81), respectively, log-rank P = .005].
Conclusion
Our study shows unique clinical and genetic correlations of TRPC6-AP, which may enable personalized care and promising novel therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
- Nephrology Department, St James's Hospital, Dublin, Ireland.
- Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
- The European Rare Kidney Disease Reference Network (ERKNet), Heidelberg, Germany.
- Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Center for Individualized Medicine, Department of Clinical Genomics, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Filippo Pinto E Vairo, Marie C Hogan, Julia Hoefele, Silvia M Titan, Alessandra Renieri, Anna Maria Pinto, Luis F Quintana, Francesca Becherucci, Erik Biros, Kendrah Kidd, Andrew J Mallett
Förderung
- Royal College of Physicians of Ireland
- MRC
- Northern Counties Kidney Research Fund
- Children's Foundation Ireland
Zitieren
APA
McAnallen, S. M., Elhassan, E. A. E., Stoneman, S., Pinto E Vairo, F., Hogan, M. C., Hoefele, J., Clince, M., Mekraksakit, P., Titan, S. M., Jorge, S., Calado, J., Decramer, S., Colliou, E., Tellier, S., Francisco, T., Servais, A., Cornet, J., de Fallois, J., Dossier, C., …, & Conlon, P. J. (2025). Genotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf086
Vancouver
McAnallen SM, Elhassan EAE, Stoneman S, Pinto E Vairo F, Hogan MC, Hoefele J, et al. Genotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf086
BibTeX
@article{McAnallen2025,
author = {McAnallen, Susan M and Elhassan, Elhussein A E and Stoneman, Sinead and Pinto E Vairo, Filippo and Hogan, Marie C and Hoefele, Julia and Clince, Michelle and Mekraksakit, Poemlarp and Titan, Silvia M and Jorge, Sofia and Calado, Joaquim and Decramer, Stéphane and Colliou, Eloïse and Tellier, Stéphanie and Francisco, Telma and Servais, Aude and Cornet, Joséphine and de Fallois, Jonathan and Dossier, Claire and Fenoglio, Roberta and Renieri, Alessandra and Pinto, Anna Maria and Daga, Sergio and Loberti, Lorenzo and Fila, Marc and Quintana, Luis F and Becherucci, Francesca and Godefroid, Nathalie and Dubrasquet, Astrid and Kálmán, Tory and Dolan, Niamh and Alawi, Bushra Al and Sweeney, Clodagh and Riordan, Michael and Stack, Maria and Awan, Atif and Hui, Ng Kar and McCarthy, Hugh J and Biros, Erik and Harris, Trudie and Kidd, Kendrah and Haeberle, Stefanie and Bleyer, Anthony J and Mallett, Andrew J and Sayer, John A and Schafer, Franz and Benson, Katherine A and McCann, Emma and Conlon, Peter J},
title = {Genotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
doi = {10.1093/ndt/gfaf086}
}
EUVIMED